American College of Radiology (ACR)

American College of Radiology Selected as Imaging Partner for VIRUS COVID-19 Registry

The Viral Infection and Respiratory Illness Universal Study (VIRUS) will evaluate safety and observational effectiveness of COVID-19 practices

Newswise — The American College of Radiology® (ACR®) Center for Research and Innovation™ (CRI) was selected by the Society of Clinical Care Medicine (SCCM) to serve as the overall imaging repository for the Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) COVID-19 Registry. The study aims to create a real time registry of current ICU and hospital care patterns to allow evaluation of safety and observational effectiveness of COVID-19 practices.

In collaboration with SCCM, the ACR CRI will collect all diagnostic images for the VIRUS COVID-19 Registry, create a link between the images and clinical data collected by SCCM, and archive images to make them accessible to participating sites through combined dashboard reporting.

“We are excited to support this effort to enhance the quality, safety and effectiveness of patient care during this public health crisis,” says Etta Pisano, MD, chief research officer of the ACR. “The utilization of both clinical and imaging data is likely to be very important in monitoring and predicting the course of the COVID-19 pandemic, particularly as it affects rural America in the months ahead. The ACR is proud to be of service to the country through this effort. This study also lays the groundwork for future collaborative efforts to harness the power of bringing data together in a federated model, while allowing study participants the autonomy to determine how much data is shared.”

The registry will be essential for near-real time observational comparative effectiveness studies to learn effective treatment strategies and/or provide meaningful hypotheses for clinical trials. A dashboard tracks data on trends such as mechanical ventilation duration, ICU length of stay, ICU discharge details and the type of medical support patients receive, as well as patient demographics: gender, age and race. Underscoring the urgent demand for such a registry, VIRUS hit its first major milestone of 1,000 patients enrolled after being open just three weeks. To date, it has collected data on more than 8,500 patients from 184 healthcare sites.

“The  Society of Critical Care Medicine is proud to have the ACR CRI as a partner in the Discovery VIRUS Registry, as both organizations strive to fulfill a shared mission to improve care for patients with COVID-19 and develop strategies for future outbreaks,” said SCCM CEO David Martin, CAE. “We are finding new ways to collaborate, share data and communicate information, moving quickly under unprecedented timelines. These strong partnership are vital to our success.”

Rahul Kashyap, MBBS, MBA of Mayo Clinic in Rochester, Minnesota serves as principal investigator; along with co-principal investigators Vishakha Kumar, MD, MBA of SCCM and Allen J. Walkey, MD, MSc of Boston University.

For more information about the Discovery VIRUS COVID-19 Registry, visit sccm.org/VIRUS.  To arrange an interview with an ACR representative, please contact Meghan Swope at 703-390-9822 or [email protected].

###

About the American College of Radiology

The American College of Radiology® (ACR®), founded in 1924, is a professional medical society dedicated to serving patients and society by empowering radiology professionals to advance the practice, science and professions of radiological care.

About the Society of Critical Care Medicine

The Society of Critical Care Medicine (SCCM) is the largest nonprofit medical organization dedicated to promoting excellence and consistency in the practice of critical care. With members in more than 100 countries, SCCM is the only organization that represents all professional components of the critical care team. The Society offers a variety of activities that ensure excellence in patient care, education, research, and advocacy. SCCM’s mission is to secure the highest quality of care for all critically ill and injured patients. Visit sccm.org for more information. Follow @SCCM or visit us on Facebook.



Filters close

Showing results

1120 of 5820
access_time Embargo lifts in 2 days
Embargo will expire: 20-Jun-2021 9:00 AM EDT Released to reporters: 13-Jun-2021 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Jun-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Jun-2021 9:00 AM EDT Released to reporters: 13-Jun-2021 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Jun-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 267646_web.jpg
Released: 11-Jun-2021 2:10 PM EDT
Saliva can be more effective than nasopharyngeal swabs for COVID-19 testing
Elsevier

The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints.

Released: 11-Jun-2021 1:25 PM EDT
Physical Activity May Curb Health Care Worker Burnout
University of Georgia

More physical activity programming could mitigate the effects of stress and improve worker mental and emotional health.

Newswise: AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare
9-Jun-2021 6:05 PM EDT
AI Predicts How Patients with Viral Infections, Including COVID-19, Will Fare
University of California San Diego Health

UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.

Released: 10-Jun-2021 5:35 PM EDT
Senolíticos reducen síntomas de COVID-19 en estudios preclínicos
Mayo Clinic

Los investigadores de Mayo Clinic y sus colegas de la Universidad de Minnesota demostraron que la COVID-19 exacerba las consecuencias nocivas de las células senescentes en el cuerpo. En estudios preclínicos, los fármacos senolíticos descubiertos en Mayo redujeron considerablemente la inflamación, la enfermedad y la mortalidad debida a la infección por covid en ratones ancianos. Los resultados se publican en la revista Science.

Released: 10-Jun-2021 5:30 PM EDT
Senolíticos reduzem os sintomas de COVID-19 em estudos pré-clínicos
Mayo Clinic

Os pesquisadores da Mayo Clinic e colegas da Universidade de Minnesota mostraram que o COVID-19 intensifica o impacto prejudicial das células senescentes no corpo. Em estudos pré-clínicos, os medicamentos senolíticos descobertos na Mayo reduziram significativamente a inflamação, a gravidade da doença e a mortalidade da infecção por COVID em camundongos mais velhos. Essas conclusões foram publicadas na revista Science.

Newswise: FresnoSTateVaxImage2.jpg
Released: 10-Jun-2021 5:25 PM EDT
CSU Campuses Join COVID-19 College Vaccine Challenge
California State University (CSU) Chancellor's Office

The CSU pledges to be a Vaccine Champion University as part of new White House effort aimed at increasing vaccinations for younger Americans.

Released: 10-Jun-2021 5:05 PM EDT
الأدوية المحللة للشيخوخة تقلل من أعراض فيروس كورونا المستجد (كوفيد-19) في الدراسات ما قبل السريرية
Mayo Clinic

أظهر باحثو مايو كلينك وزملاؤهم في جامعة مينيسوتا أن فيروس كورونا المستجد (كوفيد-19) يفاقم التأثير الضار للخلايا الشائخة في الجسم. ففي الدراسات ما قبل السريرية، قللت الأدوية المحللة لالشيخوخة التي تم اكتشافها في مايو بشكل كبير من الالتهاب والمرض والوفيات الناجمة عن عَدوى فيروس كورونا المستجد في الفئران الأكبر سنًا. النتائج منشورة في مجلة ساينس.

7-Jun-2021 7:05 AM EDT
Study Examines the Effects of COVID-19 on Human Kidney Cells
American Society of Nephrology (ASN)

• The virus that causes COVID-19 can infect and replicate in human kidney cells, but this does not typically lead to cell death. • Kidney cells that already have features of injury may be more easily infected and develop additional injury.


Showing results

1120 of 5820

close
4.45021